Tobacco harm reduction with vaporised nicotine (thrive): a feasibility trial of nicotine vaping products for smoking cessation among people living with hiv

HIGHLIGHTS

  • who: Stephanie Edwards from the School of Public Health, The University of Queensland, Brisbane, Australia have published the paper: Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV, in the Journal: (JOURNAL)
  • what: This study reports descriptive analyses of quantitative data on abstinence and associated adverse events. The authors report participants` demographic characteristics at baseline, the impact of the 12-week intervention on tobacco smoking behaviour (including on abstinence, CPD, quit attempts, quitting self-efficacy and nicotine dependency) and adverse events. Health . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?